EXPLORING THE THERAPEUTIC POTENTIAL OF CATHARANTHUS ROSEUS: UNVEILING ITS DIVERSE PHYTOCHEMICALS AND MECHANISMS OF ACTION FOR CHRONIC AND INFECTIOUS DISEASES

MEENAKSHI MALHOTRA; HIMANI RANA; SHUBHAM TANDON

doi:10.22159/ijcpr.2024v16i5.5023

Authors

MEENAKSHI MALHOTRA St. Soldier Institute of Pharmacy, Lidhran campus Behind NIT, Jalandhar-Amritsar Bypass, Jalandhar, Punjab-144001, India https://orcid.org/0000-0002-0080-1479
HIMANI RANA St. Soldier Institute of Pharmacy, Lidhran campus Behind NIT, Jalandhar-Amritsar Bypass, Jalandhar, Punjab-144001, India
SHUBHAM TANDON St. Soldier Institute of Pharmacy, Lidhran campus Behind NIT, Jalandhar-Amritsar Bypass, Jalandhar, Punjab-144001, India

DOI:

https://doi.org/10.22159/ijcpr.2024v16i5.5023

Keywords:

Catharanthus roseus, Antioxidant, Antibacterial, Antidiabetic, Anticancer, Vincristin, Vinblastine

Abstract

Medicinal plants have long been recognized for their potential in traditional medicine, offering a rich repository of phytochemicals with diverse therapeutic properties. These natural remedies often present fewer side effects when compared to synthetic agents, making them an attractive alternative. Among these botanical treasures, Catharanthus roseus (commonly known as c. roseus) has garnered significant attention due to its wide array of phytochemicals boasting various biological activities, such as antioxidant, antibacterial, antifungal, antidiabetic, and anticancer properties. C. roseus, known colloquially as Vinca rosea, has a storied history of application in treating various ailments across numerous countries. Notably, it has contributed ground-breaking compounds to clinical medicine, with vinblastine and vincristine being the first therapeutics derived from this plant. Furthermore, compounds like vindoline, vindolidine, vindolicine, and vindolinine found in the leaves of C. roseus exhibit potent antidiabetic effects. The ongoing research in recent years has unearthed novel insights that reshape our understanding of the mechanisms underlying the therapeutic potential of Vinca rosea. This burgeoning knowledge amplifies the prospects of this plant as a valuable source of bioactive substances for a wide range of therapeutic applications.

Downloads

Download data is not yet available.

References

Malar Retna A, P Ethalsha. A review of the taxonomy ethnobotany chemistry and pharmacology of Catharanthus roseus (Apocyanaceae). Int J Eng Res Technol. 2013;2(10):3899-912.

Chandrashekhar R, Pagadala JC, Bhavani NL. Vinca alkaloids from Madagascar periwinkle (Catharanthus roseus (L.) G. Don): an overview. Everymans Sci. 2021;LV(5):187-92.

Van der Heijden R, Jacobs DI, Snoeijer W, Hallard D, Verpoorte R. The catharanthus alkaloids: pharmacognosy and biotechnology. Curr Med Chem. 2004;11(5):607-28. doi: 10.2174/0929867043455846, PMID 15032608.

Almagro L, Fernandez Perez F, Pedreno MA. Indole alkaloids from Catharanthus roseus: bioproduction and their effect on human health. Molecules. 2015;20(2):2973-3000. doi: 10.3390/molecules20022973, PMID 25685907.

Das S, Sharangi AB. Madagascar periwinkle (Catharanthus roseus L.): diverse medicinal and therapeutic benefits to humankind. J Pharmacogn Phytochem. 2017;6(5):1695-701.

Zhu J, Wang M, Wen W, Yu R. Biosynthesis and regulation of terpenoid indole alkaloids in Catharanthus roseus. Pharmacogn Rev. 2015;9(17):24-8. doi: 10.4103/0973-7847.156323, PMID 26009689.

Rai SP, Rai SK, Periwinkle M. Horticultural and therapeutic potential of Catharanthus roseus: a model plant for terpenoid indole alkaloid synthesis. Agric Food. 2021;3(8):375-8.

Dubey A, Kushwaha R. A discussion on vinca plant. Journal of Pharmacognosy and Phytochemistry. 2020;9(5):27-31.

Leveque D, Jehl F. Molecular pharmacokinetics of catharanthus (vinca) alkaloids. J Clin Pharmacol. 2007;47(5):579-88. doi: 10.1177/0091270007299430, PMID 17442684.

Ferreres F, Pereira DM, Valentao P, Andrade PB, Seabra RM, Sottomayor M. New phenolic compounds and antioxidant potential of Catharanthus roseus. J Agric Food Chem. 2008;56(21):9967-74. doi: 10.1021/jf8022723, PMID 18850714.

Pham HN, Vuong QV, Bowyer MC, Scarlett CJ. Phytochemicals derived from Catharanthus roseus and their health benefits. Technologies. 2020;8(4):80. doi: 10.3390/technologies8040080.

Bhambhani S, Kirtikumar R, Kond Hare, Ashok P. Diversity in chemical structures and biological properties of plant alkaloids. Molecules. 2021 Jun;26(11):3374. doi: 10.3390/molecules26113374, PMID 34204857.

Prabha Lahare R, Yadav HS, Dashahre AK, Kumar Bisen Y. An updated review on phytochemical and pharmacological properties of Catharanthus roseus. SJMPS. 2020;6(12):759-66. doi: 10.36348/sjmps.2020.v06i12.007.

Allamsetty J, Pedada SP, Pedada N, Dhanunjayarao K. A basic review on Vinca rosea. Int J Pharmacogn Chem. 2020;1(1):31-6.

Aruna MS, Prabha MS, Priya NS, Nadendla R. Catharanthus roseus: ornamental plant is now medicinal boutique. J Drug Delivery Ther. 2015;5(3):1095. doi: 10.22270/jddt.v5i3.1095.

Gomathi B AR. Phytochemical investigation on Vinca rosea by thin layer chromatography. Res J Pharmacogn Phytochem. 2012;4(2):89-91.

Pandey SN, Khurja M. Phytochemicals and pharmacological studies of Catharanthus. World J Pharm Res. 2020;9(7):1407-15. doi: 10.20959/wjpr20207-17993.

Nilima WP, PW Pravara. Vinca rosea: as an potent anti-cancer agent nilima wpd and pw pravara wadi take. World J Pharm Res. 2022;11(1):781-94. doi: 10.20959/wjpr20221-22725ake.

Kohlmuzer S. Alkaloids of Catharanthus roseus (L.) G. dona new group of biologically active compounds. Postep Biochem. 1968;14(2):209-32. PMID 4872670.

Asija R, Samariya S, Khanijau R, Verma T. A pharmacological review on Catharanthus roseus linn. 2022;7(3):73-9.

Kaur H. Constituent phytochemicals from Catharanthus roseus. Afr J Biomed Res. 2020;23(1):9-15.

Cheng GG, Zhao HY, Liu L, Zhao YL, Song CW, Gu J. Non alkaloid constituents of Vinca major. Chin J Nat Med. 2016;14(1):56-60. doi: 10.3724/SP.J.1009.2016.00056, PMID 26850347.

Moudi M, Go R, Yien CY, Nazre M. Vinca alkaloids. Int J Prev Med. 2013;4(11):1231-5. PMID 24404355, PMCID PMC3883245.

Roepke J, Salim V, Wu M, Thamm AM, Murata J, Ploss K. Vinca drug components accumulate exclusively in leaf exudates of Madagascar periwinkle. Proceedings of the Natl Acad Sci United States Am. 2010;107(34):15287-92. doi: 10.1073/pnas.0911451107.

Jarald EE, Jarald E, Sheeja E, Motwani SK, Goel D, R. Comparative evaluation of antihyperglycaemic and hypoglycaemic activity of various parts of Catharanthus roseus linn. Res J Med Plants. 2008;2(1):10-5.

Kulkarni RN, Baskaran K, Chandrashekara RS, Kumar S. Inheritance of morphological traits of periwinkle mutants with modified contents and yields of leaf and root alkaloids. Plant Breed. 1999;118(1):71-4. doi: 10.1046/j.1439-0523.1999.118001071.x.

Ranjan R, Kumar M. Biochemical profile of Vinca rosea linn (Catharanthus roseus G. J Biotechnol Biochem. 2020;6(5):13-26. doi: 10.9790/264X-0605021326.

Williams CA, Grayer RJ. Anthocyanins and other flavonoids. Nat Prod Rep. 2004;21(4):539-73. doi: 10.1039/b311404j, PMID 15282635.

Al Rashed S, Baker A, Ahmad SS, Syed A, Bahkali AH, Elgorban AM. Vincamine a safe natural alkaloid represents a novel anticancer agent. Bioorg Chem. 2021;107:104626. doi: 10.1016/j.bioorg.2021.104626, PMID 33450545.

Hosseini MJ, Mahmoodi N, Eskandari J, Bijani S, Yazdinezhad AR, Anoush M. Protective effects of Vinca herbaceous extract against scopolamine-induced behavioral disturbances and brain oxidative stress in rats. Heliyon. 2022;8(4):e09295. doi: 10.1016/j.heliyon.2022.e09295, PMID 35520614.

Kruczynski A, Poli M, Dossi R. Anti metastatic activities of vinflunine the latest vinca alkaloid in clinical development. European Journal of Cancer. 2006;42(16):2821-32. doi: 10.1016/j.ejca.2006.06.019.

Wang S, Zheng Z, Weng Y, Yu Y, Zhang D, Fan W. Angiogenesis and anti-angiogenesis activity of Chinese medicinal herbal extracts. Life Sci. 2004;74(20):2467-78. doi: 10.1016/j.lfs.2003.03.005, PMID 15010258.

Sayeed M, Jesmin MH, Sarker T, Rahman M AM. Antitumor activity of leaf extracts of Catharanthus roseus. G Don. Plant Environment Development. 2014;3(2):24-30.

Tiong SH, Looi CY, Hazni H, Arya A, Paydar M, Wong WF. Antidiabetic and antioxidant properties of alkaloids from Catharanthus roseus (L.) G. Don. Molecules. 2013;18(8):9770-84. doi: 10.3390/molecules18089770, PMID 23955322.

Hassan A. In vivo antidiarrheal activity of the ethanolic leaf extract of Catharanthus roseus Linn. (Apocyanaceae) in wistar rats. Afr J Pharm Pharmacol. 2011;5(15):1797-800. doi: 10.5897/AJPP11.505.

Patel Y, Vadgama V, Baxi S. Evaluation of hypolipidemic activity of leaf juice of Catharanthus roseus (Linn.) G. Donn. in guinea pigs. Acta Pol Pharm. 2011;68(6):927-35. PMID 22125959.

Nayak BS, Anderson M, Pinto Pereira LM. Evaluation of wound healing potential of Catharanthus roseus leaf extract in rats. Fitoterapia. 2007;78(7-8):540-4. doi: 10.1016/j.fitote.2007.06.008, PMID 17683880.

Patil PJ GJ. Antimicrobial activity of Catharanthus roseus a detailed study. Br J Pharmacol Toxicol. 2010;1(1):40-4.

Agarwal S, Jacob S, Chettri N, Bisoyi S, Tazeen A, Vedamurthy AK HH. Evaluation of in vitro anthelminthic activity of Catharan_thus roseus extract. Int J Pharm Sci Drug Res. 2011;3(3):211-3.

Singh N, Pandey BR, PV. An overview of phytotherapeutic approach in prevention and treatment of Alzheimer syndrome and dementia. Int J Pharm Sci Drug Res. 2011;3(3):162-72.

Hassan A. In vivo antidiarrheal activity of the ethanolic leaf extract of Catharanthus roseus Linn. (Apocyanaceae) in wistar rats. Afr J Pharm Pharmacol. 2011;5(15):1797-800. doi: 10.5897/AJPP11.505.

Ahmed M, Sahibzada MU, Rasheed HM, Khan T, Wahid F, Farooq U. Inhibition of inflammation associated corneal neovascularization by dalbergia sissoo and Catharanthus roseus leaf extracts in an animal model. S Afr J Bot. 2022;151:379-86. doi: 10.1016/j.sajb.2022.03.047.

Shil A, Banerjee A, Maji BK, Bishayi B, Sikdar (ne’e Bhakta) M. Multiple antibiotic-resistant staphylococcus aureus induced hepatocellular anomaly: a possible amelioration by Catharanthus roseus (L.) G.Don. S Afr J Bot. 2022;148:446-59. doi: 10.1016/j.sajb.2022.05.014.

Boyette Davis JA, Cata JP, Driver LC, Novy DM, Bruel BM, Mooring DL. Persistent chemo neuropathy in patients receiving the plant alkaloids paclitaxel and vincristine. Cancer Chemother Pharmacol. 2013;71(3):619-26. doi: 10.1007/s00280-012-2047-z, PMID 23228992.

Ali R, Mirza Z, Ashraf GM, Kamal MA, Ansari SA, Damanhouri GA. New anticancer agents: recent developments in tumor therapy. Anticancer Res. 2012;32(7):2999-3005. PMID 22753764.

Ehrhardt H, Pannert L, Pfeiffer S, Wachter F, Amtmann E, Jeremias I. Enhanced antitumour effects of vinca alkaloids given separately from cytostatic therapies. Br J Pharmacol. 2013;168(7):1558-69. doi: 10.1111/bph.12068, PMID 23186127.

Kruczynski A, Colpaert F, Tarayre JP, Mouillard P, Fahy J, Hill BT. Preclinical in vivo antitumor activity of vinflunine a novel fluorinated Vinca alkaloid. Cancer Chemother Pharmacol. 1998;41(6):437-47. doi: 10.1007/s002800050764, PMID 9554586.

Braguer D. Barret J Marc, Mcdaid H, Kruczynski A. Antitumor act vinflunine eff pathw potential synergies. Semin Oncol. 2008;35(3):13-21. doi: 10.1053/j.seminoncol.2008.01.011, PMID 18538174.

Zhang Y, Yang S Hui, Guo X LI. New insights into vinca alkaloids resistance mechanism and circumvention in lung cancer; 2017. p. 1-42.

Li C, Wood JC, Vu AH, Hamilton JP, Rodriguez Lopez CE, Payne RM. Single cell multi-omics in the medicinal plant Catharanthus roseus. Nat Chem Biol. 2023;19(8):1031-41. doi: 10.1038/s41589-023-01327-0, PMID 37188960.

Zhang J, Hansen LG, Gudich O, Viehrig K, Lassen LM, Schrübbers L. A microbial supply chain for production of the anti-cancer drug vinblastine. Nature. 2022;609(7926):341-7. doi: 10.1038/s41586-022-05157-3, PMID 36045295.

Emanuela M, Giuseppe C, Sonia C. Vinca alkaloids and analogues as anticancer agents: looking back peering ahead. Bioorg Med Chem Lett. 2018;28(17):2816-26. doi: 10.1016/j.bmcl.2018.06.044.

Rajan RI. Biochemical profile of Vinca rosea linn. J Biotechnol Biochem. 2020;6(5):13-26. doi: 10.9790/264X-0605021326.

Zheng J, Deng L, Chen M, Xiao X, Xiao S, Guo C. Elaboration of thorough simplified vinca alkaloids as antimitotic agents based on pharmacophore similarity. Eur J Med Chem. 2013;65:158-67. doi: 10.1016/j.ejmech.2013.04.057, PMID 23708010.

Rowinsky E, Kufe DW, Pollock RE, Weichselbaum RR. The vinca alkaloids. Holland Frei cancer Med Hamilton, editor: BC Decker. 6th edition; 2003.

Meena M, Pasupathy K. Antidiabetic activity of Catharanthus roseus in alloxan-induced diabetics rats. Asian J Microbiol Biotechnol Environ Sci. 2006;8(2):209-12.

Azam K, Rasheed MA, Omer MO, Altaf I, Akhlaq A. Anti-hyperlipidemic and anti-diabetic evaluation of ethanolic leaf extract of Catharanthus roseus alone and in combination therapy. Braz J Pharm Sci. 2022;58. doi: 10.1590/s2175-97902020000118672.

Islam MA, Akhtar MA, Khan MR, Hossain MS, Alam AH, Ibne Wahed MI. Oral glucose tolerance test (OGTT) in normal control and glucose-induced hyperglycemic rats with coccinia cordifolia L. and Catharanthus roseus L. Pak J Pharm Sci. 2009;22(4):402-4. PMID 19783519.

Ahmed MF, Kazim SM, Ghori SS, Mehjabeen SS, Ahmed SR, Ali SM. Antidiabetic activity of Vinca rosea extracts in alloxan induced diabetic rats. Int J Endocrinol. 2010;2010:841090. doi: 10.1155/2010/841090, PMID 20652054.

Singh SN, Vats P, Suri S, Shyam R, Kumria MM, Ranganathan S. Effect of an antidiabetic extract of Catharanthus roseus on enzymic activities in streptozotocin-induced diabetic rats. J Ethnopharmacol. 2001;76(3):269-77. doi: 10.1016/s0378-8741(01)00254-9, PMID 11448549.

Nammi S, Boini MK, Lodagala SD, Behara RB. The juice of fresh leaves of Catharanthus roseus Linn. reduces blood glucose in normal and alloxan diabetic rabbits. BMC Complement Altern Med. 2003;3:4. doi: 10.1186/1472-6882-3-4, PMID 12950994.

Naz S, Haq R, Aslam F, Ilyas S. Evaluation of antimicrobial activity of extracts of in vivo and in vitro grown Vinca rosea L. (Catharanthus roseus) against pathogens. Pak J Pharm Sci. 2015;28(3):849-53. PMID 26004716.

Grujic S, Radojevic I, Vasic S, Comic L, Topuzovic M. Antimicrobial activity and some phytochemical analysis of two extracts Vinca minor L. Kragujev J Sci. 2014;36(36):145-54. doi: 10.5937/kgjsci1436145g.

Jayakumar D, Jhancy Mary S, Jaya Santhi R. Evaluation of antioxidant potential and antibacterial activity of Calotropis gigantea and Vinca rosea using in vitro model. Indian J Sci Technol. 2010;3(7):720-3. doi: 10.17485/ijst/2010/v3i7/29801.

Rajput MS, Nair V, Akansha Chauhan HJ, VD. Evaluation of antidiarrheal activity of aerial parts of Vinca major in experimental animals. Middle East J Sci Res. 2011;7(5):784-8.

Nayak S. Influence of ethanol extract of Vinca rosea on wound healing in diabetic rats. Online J Biol Sci. 2006;6(2):51-5. doi: 10.3844/ojbsci.2006.51.55.

Lakkim V, Reddy MC, Pallavali RR, Reddy KR, Reddy CV, Inamuddin. Green synthesis of silver nanoparticles and evaluation of their antibacterial activity against multidrug-resistant bacteria and wound healing efficacy using a murine model. Antibiotics (Basel). 2020;9(12):1-22. doi: 10.3390/antibiotics9120902, PMID 33322213.

Islam MA, Akhtar MA, Islam MR, Hossain MS, Alam MK, Wahed MI. Antidiabetic and hypolipidemic effects of different fractions of Catharanthus roseus (linn.) on normal and streptozotocin induced diabetic rats. J Sci Res. 2009;1(2):334-44. doi: 10.3329/jsr.v1i2.1075.

Iweala EE, Okeke CU. Comparative study of the hypoglycemic and biochemical effects of Catharanthus roseus (Linn) G. Apocynaceae (Madagascar periwinkle) and chlorpropamide (diabenese) on alloxan-induced diabetic rats. Biokemistri. 2005;17(2):149-56. doi: 10.4314/biokem.v17i2.32601.

Aboelnaga SM. Evaluation of the antihyperlipidemic and antioxidant effects of Catharanthus roseus extracted from Vinca minor in diabetic rats. J Pharm Res Int. 2021;33(2):1-13. doi: 10.9734/JPRI/2021/v33i231142.

Abdel Salam OM, Oraby FH, Hassan NS. Vinpocetine ameliorates acute hepatic damage caused by administration of carbon tetrachloride in rats. Acta Biol Hung. 2007;58(4):411-9. doi: 10.1556/ABiol.58.2007.4.8, PMID 18277467.

Adekomi DA. Madagascar periwinkle (Catharanthus roseus) enhances kidney and liver functions in Wistar rats. Int J Biomed Heal Sci. 2010;6(4):245-54.

Chauhan P, Kumar RR, Mendiratta SK. Evaluation of pancreatic lipase inhibition activity and antioxidant potential of Vinca rosea leaves. J Pharmacogn Phytochem. 2019;8(3):3368-72.

Hosseini MJ, Mahmoodi N, Eskandari J, Bijani S, Yazdinezhad AR, Anoush M. Protective effects of Vinca herbaceous extract against scopolamine-induced behavioral disturbances and brain oxidative stress in rats. HeliyonHeliyon. 2022;8(4):e09295. doi: 10.1016/j.heliyon.2022.e09295, PMID 35520614.

Renushe AP, Banothu AK, Bharani KK, Mekala L, Kumar JM, Neeradi D. Vincamine an active constituent of Vinca rosea ameliorates experimentally induced acute lung injury in swiss albino mice through modulation of Nrf-2/NF-κB signaling cascade. Int Immunopharmacol. 2022;108:108773. doi: 10.1016/j.intimp.2022.108773.

Aslam MS, Ahmad MS, Ahmad MA, Akhlaq M. An updated review on phytochemical and pharmacological propeties of piper sarmentosum. Curr Trends Biotechnol Pharm. 2017;11(4):345-56.

Singh R, Pathak J, Dubey P. Catharanthus roseus: a pharmaceutical resource for human diseases. 2018;5(4):19-24.

Kumar S, Singh B, Singh R. Catharanthus roseus (L.) G. Don: a review of its ethnobotany phytochemistry ethnopharmacology and toxicities. J Ethnopharmacol. 2022;284:114647. doi: 10.1016/j.jep.2021.114647, PMID 34562562.